DAFNA Capital Management, LLC

Entreprise	Partager, %
Stereotaxis, Inc.	20.73
TELA Bio, Inc.	3.64
Inogen, Inc.	2.23
Aprea Therapeutics, Inc.	1.96
Regulus Therapeutics Inc.	1.7
ProQR Therapeutics N.V.	1.49
Century Therapeutics, Inc.	0.95
BrainsWay Ltd.	0.67